Research Article

Analysis of Complications and Risk Factors Other than Bleeding before and after Endoscopic Treatment of Esophagogastric Variceal Bleeding in Patients with Liver Cirrhosis

Table 2

Univariate and multivariate analyses of risk factors for patients with extra-hemorrhagic complications at admission (logistic regression).

CharacteristicsSingle factor analysisMultifactor analysis
OR95% CIOR95% CI

Gender (female)1.130.78–1.660.52
Age (years old)1.021.01–1.0350.0111.0390.942–1.1450.444
Time of cirrhosis was found (years)11–1.010.031.0020.998–1.0050.411
BMI0.9720.94–1.0050.121
Blood pressure0.670.44–10.051
Heart rate1.260.75–2.110.38
Liver and palm spider nevus (yes)1.030.65–1.630.89
History of splenectomy (yes)0.3180.171–0.593<0.0010.3920.153–1.0050.051
Education level primary school vs. none0.70.36–1.380.3
Education level: junior high vs. none0.610.31–1.210.16
Education level: high school vs. none0.680.32–1.440.31
University education or above vs. none0.520.14–1.890.32
Smoking (yes)1.130.73–1.740.59
Drink alcohol (yes)1.190.81–1.740.38
Antiviral drug use. No vs. yes0.940.64–1.360.73
Whether to take beta blockers. No vs. yes0.520.11–2.540.42
Etiology of cirrhosis: Posthepatitic C vs. posthepatitic B2.040.42–9.990.38
Etiology of cirrhosis. Alcoholic cirrhosis vs. posthepatitis B cirrhosis0.850.47–1.530.58
Etiology of cirrhosis. Mixed cirrhosis vs. posthepatitis B cirrhosis2.110.93–4.790.07
Etiology of cirrhosis. Autoimmune cirrhosis vs. posthepatitis B cirrhosis0.650.24–1.750.4
Etiology of cirrhosis: Cholestatic cirrhosis vs. posthepatitis B cirrhosis2.040.89–4.640.09
Schistosomiasis is the cause of cirrhosis0.580.16–2.060.4
Etiology of cirrhosis. Unknown cause vs. posthepatitis B cirrhosis1.110.69–1.790.66
Diabetes (yes)0.880.55–1.390.58
HBV titer PCR.IUML0.710.39–1.290.27
Degree of esophageal and fundus varices. Heavy vs. medium1.1570.691–1.9360.58
The treatment of varicose veins. Sclerotherapy vs. ligation1.170.75–1.820.49
The treatment of varicose veins. Tissue glue vs. ligation1.40.48–4.070.53
The treatment of varicose veins. Combination therapy vs. ligation0.870.56–1.350.55
Grading of child1.161.06–1.26<0.0011.2041.068–1.3570.002
Whether it is complicated with liver cancer (yes)0.750.4–1.420.38
Portal hypertensive gastropathy (yes)1.430.82–2.510.21
D-dimer1.221.09–1.36<0.0011.131–1.2810.051
International standardized ratio (INR)1.870.81–4.340.15
Prothrombin time (PT)10.96–1.030.82
Alanine aminotransferase (ALT)11–1.010.18
Aspartic acid aminotransferase (AST)11–10.14
Aspartate aminotransferase. (AST), platelets (PLT), APRI1.150.98–1.360.09
Albumin (ALB)0.960.93–0.980.0031.0160.962–1.0730.563
γ Glutamine transferase. Gamma GT11–10.81
Alkaline phosphatase (ALP)11–1.010.011.0010.999–1.0040.278
Total bilirubin (TBil)1.011–1.020.26
Creatinine (Cr)10.99–1.010.8
The urea1.061–1.130.06
Glomerular filtration rate (GFR)10.99–1.010.84
Triglyceride trifat1.030.95–1.110.47
Cholesterol0.890.72–1.10.29
Blood calcium0.30.1–0.920.040.5940.101–3.4990.565
Serum sodium0.970.93–1.020.27
Neutrophils (Neu)1.181.06–1.31<0.0010.80.424–1.5070.489
Lymphocyte count (LYM)0.980.85–1.130.75
Neutrophils. Ratio of neutrophils to lymphocytes1.141.05–1.240.0021.1890.999–1.4160.052
White blood cell (WBC) count1.141.05–1.23<0.0011.1810.733–1.9020.494
Hemoglobin (Hb)0.990.99–10.07
Platelet count (PLT)11–1.010.011.0010.997–1.0050.604
Erythrocyte distribution width. RDW. CV1.060.99–1.130.08
CLIF-C Ads1.0761.025–1.1310.0030.9230.662–1.2860.636

CLIF-C Ads, CLIF consortium acute decompensation score; OR, odds ratio; CI, confidence interval.